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Abstract. Epithelial cancers, including those of the skin and cervix, are the most common type of cancers in humans. Many
recent studies have attempted to use Raman spectroscopy to diagnose these cancers. In this paper, Raman spectral markers related
to the temporal and spatial effects of cervical and skin cancers are examined through four separate but related studies. Results
from a clinical cervix study show that previous disease has a significant effect on the Raman signatures of the cervix, which allow
for near 100% classification for discriminating previous disease versus a true normal. A Raman microspectroscopy study showed
that Raman can detect changes due to adjacent regions of dysplasia or HPV that cannot be detected histologically, while a clinical
skin study showed that Raman spectra may be detecting malignancy associated changes in tissues surrounding nonmelanoma
skin cancers. Finally, results of an organotypic raft culture study provided support for both the skin and the in vitro cervix results.
These studies add to the growing body of evidence that optical spectroscopy, in this case Raman spectral markers, can be used to
detect subtle temporal and spatial effects in tissue near cancerous sites that go otherwise undetected by conventional histology.
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1. Introduction
Epithelial cancers are the most common type of can-
cers in humans, comprising over 90% of cancer cas-
es [1]. They can arise from external, or surface epithe-
lia, which include skin, cervix, large intestine, lung, and
stomach; or internal epithelia, which include breast,
prostate, ovary, bladder, and pancreas [1]. The epithe-
lium is the most common cancer site because of the
constant turn-over and repair of these cells, as well as
possible exposure to environmental or other exogenous
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factors such as viruses. This paper will focus on two
specific epithelial cancers, those of the cervix and the
skin, both of which have been expressly targeted for
interrogation by optical spectroscopy.
1.1. Cervical cancer
Each year up to 1 million women in the US are di-
agnosed with cervical dysplasia, most of whom are
between the ages of 25–35. Without treatment, it is
possible that 30%–50% of cases may progress to in-
vasive cancer [2]. Most cervical dysplasias begin at
the squamocolumnar junction, where the squamous and
columnar epithelia meet, and can be divided into low
grade squamous intraepithelial lesions (LGSIL, or mild
dysplasia) and high grade squamous intraepithelial le-
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sions (HGSIL, or moderate and severe dysplasia and
carcinoma-in-situ (CIS)) [3–5]. Many cervical lesions
can be associated with infection by the human papillo-
ma virus (HPV), which can produce characteristic ep-
ithelial proliferation leading to malignant transforma-
tions. There are several HPV strains that can induce
this transformation, primarily strains 16 and 18 [3],
which can be protected against by the Gardasil vaccine.
However, over 80% of cervical cancer cases worldwide
occur in developing countries [6], so it is expected that
cervical cancer will continue to be a significant medical
problem of the near future.
In current medical practice, an annual Pap smear is
the primary screening method for cervical dysplasia.
Although the incidence of cervical cancer in the US has
decreased since the Pap smear became common prac-
tice, the incidence of cervical precancer has actually
increased [7,8]. The specificity of the Pap smear is
generally very high (around 95%) [9], but its sensitivity
can be as low as 20 to 50% depending on the prevalence
of the disease within the population [10]. Colposcopy
usually follows an abnormal Pap smear in the United
States and is used to direct the taking of biopsies [8].
Colposcopy has a comparatively high degree of accu-
racy in pin-pointing the area and grade of lesions [11],
but this procedure requires extensive training, and its
sensitivity is variable and limited, even in the hands of
expert practitioners [12]. To overcome these diagnostic
shortcomings, a real-time, non-invasive tool that can
not only detect cervical dysplasia but also follow the
progression of cervical disease is needed. Such a tool
could also be used as a “see and treat” method to detect
disease and allow for treatment in a single visit to the
doctor.
1.2. Skin cancer
Skin cancer is a major problem in the United States
that continues to get worse [13]. The predominant
forms of skin cancer: melanoma, basal cell carcinoma
(BCC), and squamous cell carcinoma (SCC), account
for over half of all cancer cases in the US, and non-
melanoma cancers (BCC and SCC) account for over
95% of the 1.3 million new cases of skin cancer each
year [13]. BCC arises from the basal layer of the epi-
dermis and can invade upward or downward into sur-
rounding tissue, but it very rarely metastasizes. SCC
arises from suprabasal keratinocytes and will occasion-
ally metastasize as it locally invades tissue, typically
toward deeper strata [13].
Current diagnostic methods for skin cancer rely on
initial visual inspection, which can often err towards
false positive diagnosis, and tissue biopsy, which is a
subjective and slow procedure [13]. Since skin lesions
often have irregular boundaries, both laterally and ax-
ially, it is important to determine their spatial extent
to optimize treatment. Current methods to accomplish
this, like Mohs micrographic surgery and various imag-
ing modalities, suffer from speed and accuracy limi-
tations as well [13]. There is thus a need for a real-
time, non-invasive diagnostic tool that can accurately
discriminate skin cancers from numerous other clini-
cally normal or benign skin conditions, and that can
be spatially precise enough to determine lesion mar-
gins. Similar needs exist for most forms of epithelial
cancers, to improve both detection of cancerous lesions
and guidance of therapy to treat them.
1.3. Raman spectroscopy
Raman spectroscopy is a non-invasive technique
that uses inelastic light scattering to reveal informa-
tion about the biochemical content of tissues. Sever-
al groups have taken advantage of Raman’s sensitivity
to subtle biochemical changes to detect spectral mark-
ers associated with cancer in many epithelial tissues
and organs, including the cervix [14,15], bladder and
prostate [16], lung [17], skin [18,19], breast [20,21],
and the GI tract [22–24]. Due to their ease of access, the
cervix and skin have seen some of the most extensive
study.
1.3.1. Raman spectroscopy of cervix
Raman spectroscopy can be used to distinguish cervi-
cal precancers from normal and benign conditions [25,
26]. Although our group originally showed that Ra-
man can do this fairly effectively (89% sensitivity and
81% specificity), questions have been raised about the
sources of spectral variability as well as about the bi-
ological basis of the spectral differences. To examine
the issue of true normal measurements, a small study
was conducted to compare the normal spectra from
the cervices of healthy patients to normal spectra from
cervical dysplasia patients (unpublished work). The
normal ectocervix from healthy and dysplasia patients
appears identical histologically, but there are spectro-
scopic differences between the two sets of measure-
ments. In recent work, it was discovered that cervical
Raman spectra are sensitive to menopausal status and
hormonal variations as well [27]. In fact, stratifying
cervical spectra according to hormonal and menopausal
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status led to an increase in accuracy from 88% to 94%
for classifying Raman spectra as normal, metaplasia,
LGSIL, or HGSIL [28]. Since Raman is sensitive to
these kinds of changes, it is possible that variations
in previous cervical health would affect Raman signa-
tures of currently normal tissue in a similar manner,
and would need to be accounted for to further improve
the ability of Raman to detect cervical dysplasia.
1.3.2. Raman spectroscopy of skin
Given the accessibility of the skin, several modalities
of optical spectroscopy have been investigated for skin
cancer diagnosis, but Raman spectroscopy has seen
particular success [19,29–32]. In our lab, a purpose-
built handheld Raman microscope was constructed with
an axial resolution of 14 µm and lateral resolution of
1.2 µm [33] for optimal control in obtaining measure-
ments from and around various skin cancer lesions in
vivo. This device was used in a previous in vitro study to
discriminate among normal,BCC, SCC, and melanoma
samples with near 100% classification accuracy, and
100% sensitivity and specificity in detecting cancer ver-
sus normal skin [34]. It was noted that focusing the ob-
jective at the surface or 40 µm below the surface of the
skin samples provided the best discrimination results,
even though the lesions studied generally manifest in
much deeper skin strata. This finding raised the ques-
tion of whether these results are repeatable in vivo, and
what kind of biochemical processes are occurring to al-
low detection of a deep tumor by Raman measurements
obtained near the tissue surface.
1.4. Malignancy associated changes
One possible explanation for the previous findings
mentioned above is the presence of so-called malig-
nancy associated changes (MACs), a concept very sim-
ilar to and sometimes used interchangeably with the
idea of a cancer “field effect” [35,36]. MACs refer
to biochemical changes, such as chromatin rearrange-
ment, in visually and histologically normal cells in the
vicinity of a tumor that can be detected with ultra sen-
sitive techniques like high resolution cytometry. This
idea was first proposed over 40 years ago [37–39], and
more recent studies of tissues such as lung [40–42],
cervix [43–46], and breast [47–49] have supported the
idea.
A small but growing number of studies suggest that
optical methods may be able to detect MACs. Back-
man et al. have shown the ability of enhanced elas-
tic scattering spectroscopy and four-dimensional elas-
tic light-scattering fingerprinting (4D-ELF) to detect
pre-malignant changes in colon tissue of rats, mice,
and humans [50–52]. More recently, the same group
has developed a method to predict the presence of pan-
creatic cancer without direct visualization of the pan-
creas, instead taking measurements on the adjacent
periampullary duodenal mucosa. Using 4D-ELF and
low-coherence enhanced backscattering (LEBS) spec-
troscopy, they were able to discriminate between pan-
creatic cancer patients and normal controls with 95%
sensitivity and 91% specificity [53].
1.5. Tools for evaluating spectral disease markers
Several methods can be used to evaluate and inves-
tigate the spectral disease markers present in Raman
spectra of epithelial tissues. One can use an animal
or tissue model to tightly control biological conditions
prior to acquiring Raman spectra, or one could use
microspectroscopy to attempt biochemical mapping or
other similar analysis to try to extract more information
out of the spectra.
1.5.1. Organotypic raft cultures
Organotypic raft cultures are in vitro models of ep-
ithelial tissues containing collagen and fibroblasts to
model the dermis (stroma), and layers of differentiated
keratinocytes to model the epidermis or other surface
layer. The Raman spectra of these raft cultures have
been shown to replicate the spectra of normal epithelial
tissues quite faithfully, and the spectra of raft cultures
with cancerous cells replacing keratinocytes also cor-
respond to spectra of cancerous tissue samples [54].
Since the true mechanism underlying the ability of Ra-
man to classify skin types is not known, there is a need
to discover the natures and locations of the sources of
the spectral variations that allow discrimination. Thus,
raft cultures provide a useful medium for examining
how the location of cancerous cells within an epithelial
tissue affects the Raman spectral signatures of it, both
as a whole and within individual layers. Measurements
can easily be taken at multiple time points as well to in-
vestigate temporal effects of epidermal versus stromal
disease.
1.5.2. Raman microspectroscopy
Many of the Raman spectral differences described
above were seen with probe-based measurements on
in vivo tissue, where the sampling volume is on the
order of approximately 1–2 mm3. It is therefore im-
portant to understand the biochemical and morpholog-
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ic basis of the spectral markers of disease, as well as
the basis for differences in the signatures of the tis-
sues when developing a diagnostic technique. Raman
micro-spectroscopy records spectroscopic information
from tissue with high spectral and spatial resolution,
and is thus a useful tool for understanding the biological
basis of spectral-based tissue discrimination.
1.6. Description of studies
Although Raman spectroscopy has not been used
specifically to detect malignancy associated changes or
field effects in tissue, there is growing evidence that it
may be capable of doing so, based on previous findings
in the cervix and skin and on the biochemical specificity
of the technique. In this paper, four separate but related
studies are presented in which Raman spectroscopy ap-
pears to detect tissue changes not seen by conventional
histology. These include a clinical study comparing
spectra from histologically normal cervices of healthy
patients versus those of patients with previous disease;
an in vitro cervical mapping study examining the ep-
ithelial versus stromal spectral signatures for a sample
containing disease only in the epithelial layer; a clin-
ical skin study for discriminating nonmelanoma can-
cers from normal tissue via measurements taken from
tissues outside the tumor margin; and a study using raft
cultures to examine the epidermal and stromal contri-
butions to spectra obtained from rafts with disease in
the epidermis versus disease in the stroma.
2. Materials and methods
2.1. Clinical cervix study
A total of 102 patients undergoing a routine Pap
smear were recruited to participate in the study as ap-
proved by the Copernicus and Vanderbilt Institution-
al Review Boards. To be eligible for enrollment, the
patient had to be undergoing a routine Pap smear, be
between the ages of 18–75, and still have a cervix. In-
formed consent was obtained from each patient prior
to the procedure. The cervix was exposed and visu-
ally examined by the attending physician, and the Pap
procedure was done according to standard clinical pro-
tocol. The cervix was wiped clean with a dry cotton
swab, after which Raman measurements were taken
from three locations on the ectocervix. The spectra
were considered normal if the Pap smear was negative.
The patient’s age, last period date, use of artificial hor-
mones, menopausal status, and any previous abnormal
Pap smears were all noted upon chart review.
Raman spectra were collected using a portable Ra-
man spectroscopy system consisting of a 785 nm diode
laser (Process Instruments, Inc., Salt Lake City, UT),
a beam-steered fiber optic probe (Visionex Inc., At-
lanta, GA), an imaging spectrograph (Kaiser Optical
Systems, Inc., Ann Arbor, MI), and a back-illuminated,
deep-depletion, thermo-electrically cooled charge cou-
pled device (CCD) camera (Roper Scientific, Inc.,
Princeton, NJ), all controlled with a laptop comput-
er. Details of the system have been previously report-
ed [55]. For each measurement, the fiber optic probe
delivered 80mW of incident light onto the tissue for
3 seconds, and the overhead fluorescent lights were
turned off.
Spectral calibration of the system was performed
each day using a neon-argon lamp and naphthalene
and acetaminophen standards to correct for system
wavenumber, laser excitation, and throughput varia-
tions. The spectra were processed for fluorescence sub-
traction and noise smoothing using the modified poly-
nomial fit method, described previously [55]. Follow-
ing data processing, each spectrum was normalized to
its mean spectral intensity across all Raman bands to
account for overall intensity variability.
A two-step, multi-class probabilistic algorithm was
used to classify the data in this study [56]. In the first
step, using maximum representation and discrimina-
tion feature (MRDF), the processed data set undergoes
a two-part, non-linear transform to extract relevant fea-
tures that provide the best class separation. The sec-
ond step uses sparse multinomial logistic regression
(SMLR) for classifying the MRDF output features into
corresponding tissue categories – in this case, true nor-
mal versus a history of disease. An unbiased classifi-
cation algorithm was developed using these two meth-
ods and was tested using leave-one-patient-out cross-
validation. Further details of this method have been
previously described [56].
2.2. In vitro cervix study
Informed consent was obtained from patients under-
going LEEP excision and vaginal hysterectomy, and
ethical approval for this study was obtained from the
Gloucestershire Local Ethics Committee (IRB). Cervi-
cal tissue samples, which were typically 1cm in diam-
eter, were immediately snap frozen in liquid nitrogen
upon excision. For each patient, their age, menopausal
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status, and date of last menstrual period (if applicable)
were noted.
Frozen sections with a thickness of 15–20 microns
were placed onto calcium fluoride slides for Raman
spectral mapping and stored frozen until measured. Se-
rial 7 micron sections from either side of the mapping
section were obtained and stained with hematoxylin
and eosin (H&E) for histopathological evaluation. An
expert pathologist annotated each sample with the dif-
ferent pathologies, including normal ectocervix epithe-
lium, normal endocervix epithelium, transition zone,
and LGSIL or HGSIL. Glands, stroma, and warts due
to HPV were also identified for correlation with frozen
sections.
After thawing the samples at room temperature, Ra-
man spectra were acquired using a customized Ren-
ishaw System 1000 spectrometer with StreamlineTM
technology, a novel rapid technique for Raman data ac-
quisition [57]. Raman spectra acquired from regions of
interest identified by the pathologist were acquired with
a spectral acquisition time of 40 seconds and step size of
12.7 microns in both x and y directions. Approximate-
ly 100 spectra were gathered from each region. Cos-
mic rays were removed, and background subtraction
for each spectrum was achieved by iterative subtraction
of a 5th order polynomial. Mean spectra were then
calculated for the entire selected regions from the ep-
ithelium and the stroma of different pathologies. Mean
Raman spectral features that differed among the vari-
ous pathology groups were identified and correlated to
biochemical findings in the literature.
2.3. Clinical skin study
The in-house-built Raman microspectrometer de-
scribed above [33] was used to obtain Raman mea-
surements from below the skin surface in 21 lesions
from 19 patients with suspected basal cell carcinoma
or squamous cell carcinoma. Informed consent was
obtained from these patients under a protocol approved
by the Vanderbilt IRB. Based on the results of a pre-
vious ex vivo skin cancer study [34], the clinical Ra-
man spectra were obtained from a single measurement
depth of 40 µm below the skin surface, both within a
suspected nonmelanoma lesion boundary and on ad-
jacent perilesional skin assumed to be normal. After
each Raman measurement, the location of the mea-
surement was biopsied for histopathologic correlation,
though perilesional sites were not pathologically cor-
related. The data processing and analysis were similar
to those described for the clinical cervix study, with the
discrimination algorithm classifying spectra according
to histopathologic diagnoses.
2.4. Raft culture study
Three types of raft cultures were used in this study:
normal, those with normal dermis (stroma) layers and
SCC cells (human epidermoid squamous cell carcino-
ma, A-431) in the epidermis, and those with normal
epidermis layers and SCC cells in the dermis. Normal
rafts and rafts with SCC cells in the epidermis layer
were constructed as described elsewhere [54]. For rafts
with SCC cells in the stroma layer, SCC cells were
mixed with normal fibroblasts (NHDF) in equal pro-
portions, while keeping the total number of cells in the
stroma constant compared with the other raft cultures.
An earlier study in our lab had shown that there was
no effect of varying the ratio of SCC to NHDF cells
over an order of magnitude in either direction (unpub-
lished work), so equal proportions were used for the
sake of simplicity. Only normal keratinocytes (NHK)
were used in the epidermal layer of these rafts, as for
normal rafts. Four rafts of each of the three types were
made for each experiment, and Raman spectral mea-
surements were obtained using the same system as for
the clinical cervix study, but with an integration time of
five seconds. Raman measurements were taken at 10,
15, and 20 days following the formation of the rafts.
After the last time point, one or two rafts of each type
were fixed in 10% formalin for histological processing,
and the remaining rafts had their epidermal and stromal
layers separated and measured as previously described.
All spectra, processed and calibrated as for the two
clinical studies, from each kind of raft at each time point
were averaged, and these means were compared at each
wavenumber with simple one-way ANOVA and/or a se-
ries of 2-sample t-tests. More complicated techniques
were deemed unnecessary since the goal was not to de-
velop a discrimination algorithm, but rather just to look
for any significant differences.
3. Results
3.1. Clinical cervix study
Cervical tissue Raman spectra from patients with
previous cervical disease but who currently have a
healthy cervix (the “previous abnormal” category) and
spectra from women who have had no history of cervi-
cal disease (“true normal”) are shown in Fig. 1. There
are consistent differences between the spectra at the
1250 cm−1 peak and at the shoulder around 1400 cm−1,
among other more subtle and variable differences. Ta-
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Table 1
Confusion matrix for discriminating previous cervical disease versus
true normals (i.e. no history of an abnormal Pap smear) with Raman
spectroscopy
Histopathology diagnosis
True normal Previous abnormal
Raman True normal 109 0
Diagnosis Previous abnormal 1 53
Fig. 1. Average Raman spectra from true normal cervices (110 spectra) and from cervices that are currently normal but with previous abnormal
Pap smears (53 spectra).
ble 1 shows the confusion matrix for discriminating
between these two conditions using probabilistic sta-
tistical methods. With only a single spectrum misclas-
sified, the overall accuracy of Raman spectroscopy for
determining whether or not a woman had a history of
cervical disease was greater than 99%.
3.2. Raman microspectroscopy of HPV changes in
cervix
Using a Raman microspectroscopy system, Raman
spectra were acquired from an in vitro cervix sample
that had both normal ectocervix and LGSIL associated
with mild HPV changes, as determined by an expert
pathologist. Average spectra from normal ectocervix
and LGSIL regions are shown in Fig. 2, while Fig. 3
shows the average spectra from a region of the stroma
under normal epithelium and from the stroma from
under diseased epithelium. The spectral differences
between normal cervical epithelium and HPV changes
within the same sample are fairly subtle. From Fig. 2,
slight increases in intensity can be seen at 1334 cm−1
and 1082 cm−1, both of which are usually associated
with DNA content of the cell. There are larger spectral
differences between the stroma under HPV infected
tissue and the stroma under normal tissue, as shown in
Fig. 3. Peak intensities are higher under the normal
tissue in regions from 1000 cm−1 to 1100 cm−1 and
from 1250 cm−1 to 1350 cm−1.
3.3. Clinical skin study
The Raman spectra gathered from skin (not shown)
were correctly classified by probabilistic statistical
methods for all 21 lesion spectra, and for 19 out of the
21 perilesional normals. However, morphometric mea-
surements of the H&E stained lesion cross sections re-
vealed that nearly all of the lesions manifested at depths
greater than the Raman measurement depth. Table 2
shows the measured distances from the skin surface to
the proximal margin of the lesion, as well as the ax-
ial thickness of each lesion for all of the pathologic
lesions studied (8 of the 21 suspected nonmelanomas
were histopathologically classified as scar tissue). In
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Fig. 2. Average Raman spectra from the epithelium of HPV-infected cervical tissue and from normal epithelial cervical tissue.
Fig. 3. Average Raman spectra from the stroma under HPV-infected cervical tissue and from the stroma under normal cervical tissue.
some cases, erosion of the skin’s uppermost stratum
corneum layer during histological preparation prevent-
ed absolute quantification. Yet, from this table, it is
clearly observed that nearly all of the morphometrical-
ly measurable skin lesions presented at depths greater
than the ∼47 µm measurement depth (40 µm depth of
focus + 1/2 the 14 µm axial resolution).
3.4. Raft culture results
Representative histology images of each type of raft
culture (normal, SCC in epidermis only, and SCC in
dermis only) are shown in Fig. 4. Unfortunately, raft
cultures are very prone to histology artifacts, as seen
especially in Fig. 4B, but useful information can still
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Table 2
Morphometric measurements of nonmelanoma skin cancers showing the distance
from the skin surface to the proximal tumor margin and the measured axial thickness
of the tumor. Erosion of the stratum corneum during histoprep prevented such
measurements in some cases, as noted
Sample Pathology Proximal margin depth (µm) Tumor thickness (µm)
1 BCC 89 839
2 BCC 0 554
3 BCC erosion −
4 BCC erosion −
5 BCC 234 628
6 BCC 593 394
7 BCC 49 697
8 BCC 169 359
9 BCC 888 707
10 SCC erosion −
11 SCC erosion −
12 SCC erosion −
13 SCC 223 110
be extracted. It is clear from these images that epider-
mal or dermal (stroma) layers that began as normal or
cancerous still appeared that way in these histology im-
ages, regardless of the spectroscopic findings discussed
below. That is, the epidermal layer of the stromal dis-
ease raft in Fig. 4B looks much more like the true nor-
mal epidermis from Fig. 4A than the cancerous epider-
mis from Fig. 4C. Similarly, the dermal layer under the
cancerous epidermis from Fig. 4C looks normal, like
the dermis from Fig. 4A, rather than like the cancerous
dermis seen in Fig. 4B, which contains several clusters
of SCC cells.
Since Raman spectra obtained at day 20 after raft
formation tended to show the most distinction among
the three types of rafts, and histology showed the most
“complete” models at this time point, measurements
from only day 20 of three different sets of experiments
were considered for further analysis. Figs 5 and 6 show
the mean Raman spectra obtained from separated epi-
dermis and dermis layers, respectively, from a total of
six samples each of the three types of rafts. Using
ANOVA and t-tests at the .01 significance level, a num-
ber of the observed spectral differences in the epidermal
only measurements in Fig. 5 are statistically significant.
Some of the most prominent and informative results
are found around the 1085 cm−1 and 1650 cm−1 peaks
and in the 1300 to 1330 cm−1 region, where spectra
from both raft types containing SCC cells are identi-
cal, but different from the normal rafts. These spectral
regions are generally associated with DNA and protein
content of cells. Regions where all three spectra statis-
tically differ from one another include the 1450 cm−1
peak and the 1350 cm−1 shoulder, although these dif-
ferences are not as dramatic. From Fig. 6, the spectral
differences for stromal layer measurements from the
three kinds of rafts were more substantial on the whole
compared with the epidermal results. At essentially all
major peaks and shoulder regions, statistically signifi-
cant differences could be found among all three classes
of rafts.
4. Discussion
Raman spectroscopy is a highly sensitive and specif-
ic technique used by many researchers to discriminate
cancerous tissue from normal epithelial tissue [14–24].
At times, using Raman spectroscopy to discriminate
cancerous from other types of tissues does not yield the
level of sensitivities and specificities expected based on
the apparent ability of Raman spectroscopy to detect
subtle biochemical changes. These occasional short-
comings of Raman could actually be explained in terms
of its strength, in that it is also very sensitive to tempo-
ral and spatial effects exerted on surrounding tissues by
cancerous areas, confounding efforts to rigidly classify
spectral measurements as having come from a small
number of histological based categories. Results from
the cervical and skin studies support this idea, and raft
culture findings tie these studies together.
The results from the clinical cervix study show that
previous disease has a significant effect on the Raman
signatures of the cervix. These spectra allowed for near
100% classification by probabilistic statistical meth-
ods for discriminating previous disease versus a true
normal. Many small differences can be seen in the
spectra in Fig. 1, but the largest difference occurs at
1250 cm−1, where the spectra from the previous ab-
normal are less intense than the true normal peak. This
difference could be due to a small amount of collage-
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A
B
Fig. 4. Representative histological images of (A) normal raft culture; (B) raft culture with normal epidermis and SCC cells in dermis; and (C)
raft culture with normal dermis and SCC cells in epidermis.
nous tissue left around the area where the disease had
been, since the 1250 cm−1 peak is typically associated
with collagen, or due to a number of other malignancy
associated changes that never went away but remained
undetected by standard means. In a similar manner,
previous studies have shown that it is possible to de-
tect new disease once it has started to develop, even
if disease has already occurred and then regressed or
has been treated [58]. Since Raman spectroscopy has
strong prospects for use as a screening method for cer-
vical disease, these findings need to be considered to
properly account for all sources of variation in spectra
and achieve the best diagnostic performance. Howev-
er, if Raman is used to guide biopsies, as during col-
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C
Fig. 4, continued.
poscopy, these findings do not need to be considered
because these cervices all have current evidence of dis-
ease.
The time point at which one can detect the formation
or spread of disease is an important ongoing research
topic. From Figs 2 and 3, it appears possible that
Raman spectroscopy can detect changes due to adjacent
regions of dysplasia or HPV that cannot be detected
histologically. In the diseased cervix sample studied,
dysplasia only directly affects a portion of the surface
epithelium, and no evidence of disease was found in
the stroma by a trained pathologist. In Fig. 2, spectral
differences are seen between the epithelium of a normal
versus a diseased cervix. This cervix had very mild
disease (HPV changes), so Raman spectral differences
originating from the epithelium were expected. Some
of the most prominent changes can be associated with
DNA, particularly the region around 1334 cm−1 [59]. It
is expected that as a tissue starts to become more active,
and in this case more dysplastic, the amount of cellular
proliferation and therefore the amount of DNA should
increase. This change is fairly subtle in Fig. 2 since
there is a minimal amount of disease present; in fact,
this type of disease may regress back to histologically
normal if left untreated.
The changes that are seen in the average Raman
spectra from the stroma below HPV infected tissue and
from the stroma below normal tissue, shown in Fig. 3,
are more unexpected than what is seen in Fig. 2. In
Fig. 3, two spectral regions of stroma below a normal
are more intense compared to those from stroma below
the diseased area, suggesting that disease in the epithe-
lium can indirectly affect the underlying cervix. Some
of the peak differences include those at 1316 cm−1
and 1334 cm−1, which are associated with DNA [60],
and at those associated with glycogen – 1048 cm−1,
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Fig. 5. Mean Raman spectra from the separated epidermis layers only of normal rafts, of rafts with SCC cells in the epidermis only, and of
rafts with SCC cells in the stroma only. Each spectrum is an average of three measurements taken from two different rafts over three sets of
experiments.
Fig. 6. Mean Raman spectra from the separated stroma (dermis) layers only of normal rafts, of rafts with SCC cells in the epidermis only, and
of rafts with SCC cells in the stroma only. Each spectrum is an average of three measurements taken from two different rafts over three sets of
experiments.
1083 cm−1, 1256 cm−1, and 1333 cm−1 [61]. It is
known that the glycogen in the epithelium decreases
with disease [62], but there is no mention of what hap-
pens in the stroma as a result of disease in the epitheli-
um. Other spectral differences in Fig. 3 reflect differ-
ences in the lipid and protein content of the cervix, the
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latter seen from the peaks at 1260 cm−1 to 1304 cm−1,
associated with the Amide III band [60]. Some of these
differences used as spectral markers could be due to
the nutrients in the blood being used to produce new
dysplastic cells, thereby affecting spectra from near-
by regions, or it could be that the disease has exert-
ed other effects like MACs on the surrounding tissue
without evidencing itself via standard histology. This
phenomenon needs to be studied in more detail, as the
grading of cervical dysplasia is dependant on the de-
gree of epithelium involvement. As soon as disease
invades into the stroma, it is considered cervical can-
cer, so there could be great interest in detecting early
disease markers in the stroma.
More empirical evidence for MACs being detectable
by Raman spectroscopy is provided by the clinical skin
study. With the Raman microspectrometer focused at
a depth 40 µm below the surface, the diagnostic al-
gorithm was able to discriminate between normal tis-
sue and lesions with a high rate of success. As shown
in Table 2, however, nearly all of the lesions studied
were actually situated several hundred microns below
the surface, with histologically normal tissue overlying
them. Although scattering and refractive index changes
may account for some broadening of the measurement
depth, such explanations would not account for the di-
agnostic success of the Raman technique in the major-
ity of the lesions where the proximal margin was from
around four to greater than 20 times deeper than the
depth of focus. For this reason, it is postulated that the
Raman spectra may be detecting MACs in the tissues
surrounding the tumors, and experiments are currently
underway to test this hypothesis.
The results of the raft cultures studies provide sup-
port for both the skin and the in vitro cervix results. The
relationships among the mean Raman signatures of the
separated epidermal and stromal layers, respectively, of
the rafts are shown in Figs 5 and 6, while representative
histological images of the different kinds of rafts are
shown in Fig. 4. From Fig. 6, the dermal spectral sig-
natures of rafts with normal dermis layers were signif-
icantly different compared with the stromal signatures
of the rafts with cancerous dermis layers, especially
in the region of 1300 to 1320 cm−1, which is often
increased in cancerous tissues. Comparing the dermal
layers in Fig. 4A and 4B, this result is unsurprising, as
the pockets of SCC cells in the dermis of Fig. 4B are
quite visible as clusters of dense, nucleated, dysplastic
cells. A more interesting comparison is between the
dermal layers from the normal rafts and from the rafts
with only epidermal disease. In Fig. 4 (A and C), these
dermal layers both appear normal, but as Fig. 6 shows,
the Raman spectra from the stroma under the diseased
epidermis are different from the “true normal” stroma
in much the same way as for the cervical measure-
ments in Fig. 3. Although instrumentation and tissue
differences lead to fairly different spectra between the
two figures, in each, the most prominent difference is a
lower intensity from about 1200 to 1350 cm−1 for the
spectra obtained from underneath disease rather than
under normal surface epithelia. A likely explanation
again is that the diseased epidermis is exerting some
effect on the histologically normal stroma.
The results of the skin study are supported by the
finding that Raman spectra from the epidermal layer of
rafts with SCC cells in either their epidermis or dermis
layer are nearly equivalent, as seen in Fig. 5, and that
both are distinct from the epidermal Raman signature
of normal rafts. As discussed above, the skin study
was able to discriminate lesions from healthy tissues
even when the lesions were deep in the tissue below
a sizeable layer of epidermis. As shown in Fig. 4B,
placing SCC cells in the dermis of raft cultures mim-
icked this situation by forming characteristic clusters
like they would in a tumor. This figure also shows that
the epidermis of these rafts does not visually resemble
the epidermis of the epidermal disease rafts in Fig. 4C,
even though they possess similar Raman signatures,
but it does more closely resemble the epidermis of the
normal raft in Fig. 4A, which has a notably different
Raman signature. It appears that when the SCC cells
are seeded in the stroma, they produce some sort of
biochemical signal that both draws the cells together
in clusters (this behavior is not evidenced until day
15 after formation) and influences the epidermal cells
above them to undergo malignancy associated changes
or produce other disease markers that are detectable
with Raman spectroscopy, but not with a conventional
histology preparation.
Several points still need to be addressed with regard
to raft cultures to make them even more useful for fu-
ture use in elucidating MAC-related mechanisms. Raft
cultures are good models of skin (or cervix), both struc-
turally and spectroscopically, but they are not perfect.
There are no blood vessels or inflammatory cells in the
dermis, and there is no basement membrane between
the epidermis and dermis. The latter fact may be rel-
evant in this case not only because of a missing com-
ponent that may contribute to in vivo Raman signals,
but also because its presence may affect the transmis-
sion of any biochemical signals between the dermis and
epidermis. On the other hand, this lack of a barrier
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may speed up the process to be more viable for study
in a lab setting. Instrumentation limitations at the time
of this study prevented the gathering of depth-resolved
data on intact rafts, which would be another solid piece
of supporting evidence for these findings and for the in
vivo skin findings.
The four studies presented in this paper add to the
growing body of evidence that optical spectroscopy, in
this case Raman, can detect subtle temporal and spa-
tial effects in tissue near cancerous sites that go other-
wise undetected by conventional histology. The prima-
ry temporal effect explored in this paper is the finding
that for a patient with a history of disease who is cur-
rently healthy, her Raman spectra still show significant
differences compared with someone who has never had
disease, and that these effects extend over many years.
Thus, it is very important to study this effect in oth-
er organs or tissue systems, especially those that are
prone to multiple instances of disease progression and
regression during a lifetime, so that proper “normal”
baselines can be set when making any attempt at tissue
discrimination.
It would also be interesting to examine the tempo-
ral aspects of the various spatial effects discussed in
this paper. As shown for cervix, skin, and an epithe-
lial tissue model, histologically normal tissues locat-
ed near tumors show distinct Raman spectral differ-
ences from normal tissues located further away or in
completely healthy systems. What remains to be seen
is at what time point these spatial effects are first de-
tectable, and whether areas showing these effects will
eventually become cancerous as well, or simply con-
tinue functioning in a quasi-normal but altered state.
Raft cultures would be an ideal starting point for this
kind of study because they can be plentifully made, are
easy to interrogate optically, and can be made in sev-
eral different configurations of normal versus various
types of diseased cells. These findings would have a
significant impact on the development of early screen-
ing techniques, which could provide great benefit to
patients down the line. These spatial effects also have
an impact on choosing what kind of tissue to use as a
normal reference in discrimination studies, as it must
be determined whether a “true normal” measurement
is even possible from a patient with disease, and if so,
how much distance from the diseased site is required
to ensure accurate results.
Although the results presented in this paper are hy-
pothesized to be due to malignancy associated changes
or a cancer field effect, optical spectroscopy is not nec-
essarily the answer for elucidating such mechanisms.
Rather, it excels as a tool to detect such subtle tissue
changes and disease markers, and it is important to
work with those in more purely biological fields in de-
termining what cellular and stromal changes are actu-
ally occurring, which could then lead to more focused
detection techniques and the improved ability to de-
tect early tissue changes related to the development of
cancer.
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